| Name | Title | Contact Details |
|---|
Cornell Surgical Co is a Bergenfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CCS Medical Holdings Inc. is a Clearwater, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ottobock was founded in Germany in 1919 by Otto Bock, a prosthetist. His vision of restoring mobility lives on today, growing to serve the world with more than 46 locations reaching more than 100 countries. The company is headquartered in Duderstadt, Germany, and has more than 5,000 employees. In the early 20th century, Otto Bock transformed the way prosthetic limbs were made. Instead of carving wood to fit a patient, he applied manufacturing techniques and created separate components (like knees and feet) that could be combined, altered or customized to create a limb that was still unique to each patient – but wasn’t built from scratch. Because of his pioneering work, Prosthetists were able to meet the demand generated by World War I and help veterans stay as active as possible. In 1958, our North American headquarters were established in Minneapolis, Minnesota. Our Canadian branch was founded in 1978 and is currently located in Toronto, Ontario. As the first branch, North America has led the way in advocating for and supporting local needs while still tapping into a global network of research and development, manufacturing, and clinical expertise. The people who use our products benefit from the synergy of a worldwide organization complemented by a local connection. Finally, Ottobock continues to give back to the community, supporting various charities and projects that are consistent with our mission of restoring independence.
Dansereau Health Products is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on